The Mechanism of Galactosamine Toxicity Revisited; A Metabonomic Study

1H NMR spectroscopy was used to investigate the metabolic effects of the hepatotoxin galactosamine (galN) and the mechanism by which glycine protects against such toxicity. Rats were acclimatized to a 0 or 5% glycine diet for 6 days and subsequently administered vehicle, galN (500 mg/kg), glycine (5...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of proteome research 2007-07, Vol.6 (7), p.2711-2719
Hauptverfasser: Coen, M, Hong, Y. S, Clayton, T. A, Rohde, C. M, Pearce, J. T, Reily, M. D, Robertson, D. G, Holmes, E, Lindon, J. C, Nicholson, J. K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2719
container_issue 7
container_start_page 2711
container_title Journal of proteome research
container_volume 6
creator Coen, M
Hong, Y. S
Clayton, T. A
Rohde, C. M
Pearce, J. T
Reily, M. D
Robertson, D. G
Holmes, E
Lindon, J. C
Nicholson, J. K
description 1H NMR spectroscopy was used to investigate the metabolic effects of the hepatotoxin galactosamine (galN) and the mechanism by which glycine protects against such toxicity. Rats were acclimatized to a 0 or 5% glycine diet for 6 days and subsequently administered vehicle, galN (500 mg/kg), glycine (5% via the diet), or both galN and glycine. Urine was collected over 12 days prior to administration of galN and for 24 hours thereafter. Serum and liver tissue were sampled on termination, 24 hours post-dosing. The metabolic profiles of biofluids and tissues were determined using high-field 1H NMR spectroscopy. Orthogonal-projection to latent structures discriminant analysis (O-PLS-DA) was applied to model the spectral data and enabled the hepatic, urinary, and serum metabolites that discriminated between control and treated animals to be determined. Histopathological data and clinical chemistry measurements confirmed the protective effect of glycine. The level of N-acetylglucosamine (glcNAc) in the post-dose urine was found to correlate strongly with the degree of galN-induced liver damage, and the urinary level of glcNAc was not significantly elevated in rats treated with both galN and glycine. Treatment with glycine alone was found to significantly increase hepatic levels of uridine, UDP-glucose, and UDP-galactose, and in view of the known effects of galactosamine, this suggests that the protective role of glycine against galN toxicity might be mediated by changes in the uridine nucleotide pool rather than by preventing Kupffer cell activation. Thus, we present a novel hypothesis:  that administration of glycine increases the hepatic uridine nucleotide pool which counteracts the galN-induced depletion of these pools and facilitates complete metabolism of galN. These novel data highlight the applicability of NMR-based metabonomics in elucidating multicompartmental metabolic consequences of toxicity and toxic salvage. Keywords: Metabonomics • Galactosamine Toxicity • Glycine Protection • Mechanism • NMR • O-PLS-DA
doi_str_mv 10.1021/pr070164f
format Article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_pr070164f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>a78346500</sourcerecordid><originalsourceid>FETCH-LOGICAL-a313t-b7bfd9ad62da361a56785ad97d8dccf266353613150f01d08e4f0959c5e91d7f3</originalsourceid><addsrcrecordid>eNptkE9Lw0AQxRdRbK0e_AKyFw8eojPdbjaLp1JsFSqC1nPY7B-6pcmGbCL22xtp1YuneQy_ebx5hFwi3CKM8a5uQACmE3dEhsgZT5gEcfyjM8kG5CzGDQByAeyUDFDwDDKOQzJfrS19tnqtKh9LGhxdqK3SbYiq9JWlq_DptW939NV--Ohba-7ptD9oVRGqUHpN39rO7M7JiVPbaC8Oc0Te5w-r2WOyfFk8zabLRDFkbVKIwhmpTDo2iqWoeCoyrowUJjNau3GaMt7vGXJwgAYyO3EgudTcSjTCsRG52fvqJsTYWJfXjS9Vs8sR8u8u8t8uevZqz9ZdUVrzRx6e74HrPaB0zDeha6o--j9GX1nyZSc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Mechanism of Galactosamine Toxicity Revisited; A Metabonomic Study</title><source>MEDLINE</source><source>ACS Publications</source><creator>Coen, M ; Hong, Y. S ; Clayton, T. A ; Rohde, C. M ; Pearce, J. T ; Reily, M. D ; Robertson, D. G ; Holmes, E ; Lindon, J. C ; Nicholson, J. K</creator><creatorcontrib>Coen, M ; Hong, Y. S ; Clayton, T. A ; Rohde, C. M ; Pearce, J. T ; Reily, M. D ; Robertson, D. G ; Holmes, E ; Lindon, J. C ; Nicholson, J. K</creatorcontrib><description>1H NMR spectroscopy was used to investigate the metabolic effects of the hepatotoxin galactosamine (galN) and the mechanism by which glycine protects against such toxicity. Rats were acclimatized to a 0 or 5% glycine diet for 6 days and subsequently administered vehicle, galN (500 mg/kg), glycine (5% via the diet), or both galN and glycine. Urine was collected over 12 days prior to administration of galN and for 24 hours thereafter. Serum and liver tissue were sampled on termination, 24 hours post-dosing. The metabolic profiles of biofluids and tissues were determined using high-field 1H NMR spectroscopy. Orthogonal-projection to latent structures discriminant analysis (O-PLS-DA) was applied to model the spectral data and enabled the hepatic, urinary, and serum metabolites that discriminated between control and treated animals to be determined. Histopathological data and clinical chemistry measurements confirmed the protective effect of glycine. The level of N-acetylglucosamine (glcNAc) in the post-dose urine was found to correlate strongly with the degree of galN-induced liver damage, and the urinary level of glcNAc was not significantly elevated in rats treated with both galN and glycine. Treatment with glycine alone was found to significantly increase hepatic levels of uridine, UDP-glucose, and UDP-galactose, and in view of the known effects of galactosamine, this suggests that the protective role of glycine against galN toxicity might be mediated by changes in the uridine nucleotide pool rather than by preventing Kupffer cell activation. Thus, we present a novel hypothesis:  that administration of glycine increases the hepatic uridine nucleotide pool which counteracts the galN-induced depletion of these pools and facilitates complete metabolism of galN. These novel data highlight the applicability of NMR-based metabonomics in elucidating multicompartmental metabolic consequences of toxicity and toxic salvage. Keywords: Metabonomics • Galactosamine Toxicity • Glycine Protection • Mechanism • NMR • O-PLS-DA</description><identifier>ISSN: 1535-3893</identifier><identifier>EISSN: 1535-3907</identifier><identifier>DOI: 10.1021/pr070164f</identifier><identifier>PMID: 17580851</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Acetylglucosamine - analysis ; Animals ; Diet ; Galactosamine - antagonists &amp; inhibitors ; Galactosamine - toxicity ; Glycine - administration &amp; dosage ; Glycine - blood ; Glycine - urine ; Kupffer Cells - chemistry ; Kupffer Cells - drug effects ; Liver - chemistry ; Liver - drug effects ; Liver - metabolism ; Male ; Nuclear Magnetic Resonance, Biomolecular - methods ; Rats ; Rats, Sprague-Dawley ; Serum - chemistry ; Uridine - analysis ; Uridine Diphosphate Galactose - analysis ; Uridine Diphosphate Glucose - analysis ; Urine - chemistry</subject><ispartof>Journal of proteome research, 2007-07, Vol.6 (7), p.2711-2719</ispartof><rights>Copyright © 2007 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a313t-b7bfd9ad62da361a56785ad97d8dccf266353613150f01d08e4f0959c5e91d7f3</citedby><cites>FETCH-LOGICAL-a313t-b7bfd9ad62da361a56785ad97d8dccf266353613150f01d08e4f0959c5e91d7f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/pr070164f$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/pr070164f$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>315,781,785,2766,27078,27926,27927,56740,56790</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17580851$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Coen, M</creatorcontrib><creatorcontrib>Hong, Y. S</creatorcontrib><creatorcontrib>Clayton, T. A</creatorcontrib><creatorcontrib>Rohde, C. M</creatorcontrib><creatorcontrib>Pearce, J. T</creatorcontrib><creatorcontrib>Reily, M. D</creatorcontrib><creatorcontrib>Robertson, D. G</creatorcontrib><creatorcontrib>Holmes, E</creatorcontrib><creatorcontrib>Lindon, J. C</creatorcontrib><creatorcontrib>Nicholson, J. K</creatorcontrib><title>The Mechanism of Galactosamine Toxicity Revisited; A Metabonomic Study</title><title>Journal of proteome research</title><addtitle>J. Proteome Res</addtitle><description>1H NMR spectroscopy was used to investigate the metabolic effects of the hepatotoxin galactosamine (galN) and the mechanism by which glycine protects against such toxicity. Rats were acclimatized to a 0 or 5% glycine diet for 6 days and subsequently administered vehicle, galN (500 mg/kg), glycine (5% via the diet), or both galN and glycine. Urine was collected over 12 days prior to administration of galN and for 24 hours thereafter. Serum and liver tissue were sampled on termination, 24 hours post-dosing. The metabolic profiles of biofluids and tissues were determined using high-field 1H NMR spectroscopy. Orthogonal-projection to latent structures discriminant analysis (O-PLS-DA) was applied to model the spectral data and enabled the hepatic, urinary, and serum metabolites that discriminated between control and treated animals to be determined. Histopathological data and clinical chemistry measurements confirmed the protective effect of glycine. The level of N-acetylglucosamine (glcNAc) in the post-dose urine was found to correlate strongly with the degree of galN-induced liver damage, and the urinary level of glcNAc was not significantly elevated in rats treated with both galN and glycine. Treatment with glycine alone was found to significantly increase hepatic levels of uridine, UDP-glucose, and UDP-galactose, and in view of the known effects of galactosamine, this suggests that the protective role of glycine against galN toxicity might be mediated by changes in the uridine nucleotide pool rather than by preventing Kupffer cell activation. Thus, we present a novel hypothesis:  that administration of glycine increases the hepatic uridine nucleotide pool which counteracts the galN-induced depletion of these pools and facilitates complete metabolism of galN. These novel data highlight the applicability of NMR-based metabonomics in elucidating multicompartmental metabolic consequences of toxicity and toxic salvage. Keywords: Metabonomics • Galactosamine Toxicity • Glycine Protection • Mechanism • NMR • O-PLS-DA</description><subject>Acetylglucosamine - analysis</subject><subject>Animals</subject><subject>Diet</subject><subject>Galactosamine - antagonists &amp; inhibitors</subject><subject>Galactosamine - toxicity</subject><subject>Glycine - administration &amp; dosage</subject><subject>Glycine - blood</subject><subject>Glycine - urine</subject><subject>Kupffer Cells - chemistry</subject><subject>Kupffer Cells - drug effects</subject><subject>Liver - chemistry</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Nuclear Magnetic Resonance, Biomolecular - methods</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Serum - chemistry</subject><subject>Uridine - analysis</subject><subject>Uridine Diphosphate Galactose - analysis</subject><subject>Uridine Diphosphate Glucose - analysis</subject><subject>Urine - chemistry</subject><issn>1535-3893</issn><issn>1535-3907</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkE9Lw0AQxRdRbK0e_AKyFw8eojPdbjaLp1JsFSqC1nPY7B-6pcmGbCL22xtp1YuneQy_ebx5hFwi3CKM8a5uQACmE3dEhsgZT5gEcfyjM8kG5CzGDQByAeyUDFDwDDKOQzJfrS19tnqtKh9LGhxdqK3SbYiq9JWlq_DptW939NV--Ohba-7ptD9oVRGqUHpN39rO7M7JiVPbaC8Oc0Te5w-r2WOyfFk8zabLRDFkbVKIwhmpTDo2iqWoeCoyrowUJjNau3GaMt7vGXJwgAYyO3EgudTcSjTCsRG52fvqJsTYWJfXjS9Vs8sR8u8u8t8uevZqz9ZdUVrzRx6e74HrPaB0zDeha6o--j9GX1nyZSc</recordid><startdate>200707</startdate><enddate>200707</enddate><creator>Coen, M</creator><creator>Hong, Y. S</creator><creator>Clayton, T. A</creator><creator>Rohde, C. M</creator><creator>Pearce, J. T</creator><creator>Reily, M. D</creator><creator>Robertson, D. G</creator><creator>Holmes, E</creator><creator>Lindon, J. C</creator><creator>Nicholson, J. K</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200707</creationdate><title>The Mechanism of Galactosamine Toxicity Revisited; A Metabonomic Study</title><author>Coen, M ; Hong, Y. S ; Clayton, T. A ; Rohde, C. M ; Pearce, J. T ; Reily, M. D ; Robertson, D. G ; Holmes, E ; Lindon, J. C ; Nicholson, J. K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a313t-b7bfd9ad62da361a56785ad97d8dccf266353613150f01d08e4f0959c5e91d7f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Acetylglucosamine - analysis</topic><topic>Animals</topic><topic>Diet</topic><topic>Galactosamine - antagonists &amp; inhibitors</topic><topic>Galactosamine - toxicity</topic><topic>Glycine - administration &amp; dosage</topic><topic>Glycine - blood</topic><topic>Glycine - urine</topic><topic>Kupffer Cells - chemistry</topic><topic>Kupffer Cells - drug effects</topic><topic>Liver - chemistry</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Nuclear Magnetic Resonance, Biomolecular - methods</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Serum - chemistry</topic><topic>Uridine - analysis</topic><topic>Uridine Diphosphate Galactose - analysis</topic><topic>Uridine Diphosphate Glucose - analysis</topic><topic>Urine - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coen, M</creatorcontrib><creatorcontrib>Hong, Y. S</creatorcontrib><creatorcontrib>Clayton, T. A</creatorcontrib><creatorcontrib>Rohde, C. M</creatorcontrib><creatorcontrib>Pearce, J. T</creatorcontrib><creatorcontrib>Reily, M. D</creatorcontrib><creatorcontrib>Robertson, D. G</creatorcontrib><creatorcontrib>Holmes, E</creatorcontrib><creatorcontrib>Lindon, J. C</creatorcontrib><creatorcontrib>Nicholson, J. K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of proteome research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coen, M</au><au>Hong, Y. S</au><au>Clayton, T. A</au><au>Rohde, C. M</au><au>Pearce, J. T</au><au>Reily, M. D</au><au>Robertson, D. G</au><au>Holmes, E</au><au>Lindon, J. C</au><au>Nicholson, J. K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Mechanism of Galactosamine Toxicity Revisited; A Metabonomic Study</atitle><jtitle>Journal of proteome research</jtitle><addtitle>J. Proteome Res</addtitle><date>2007-07</date><risdate>2007</risdate><volume>6</volume><issue>7</issue><spage>2711</spage><epage>2719</epage><pages>2711-2719</pages><issn>1535-3893</issn><eissn>1535-3907</eissn><abstract>1H NMR spectroscopy was used to investigate the metabolic effects of the hepatotoxin galactosamine (galN) and the mechanism by which glycine protects against such toxicity. Rats were acclimatized to a 0 or 5% glycine diet for 6 days and subsequently administered vehicle, galN (500 mg/kg), glycine (5% via the diet), or both galN and glycine. Urine was collected over 12 days prior to administration of galN and for 24 hours thereafter. Serum and liver tissue were sampled on termination, 24 hours post-dosing. The metabolic profiles of biofluids and tissues were determined using high-field 1H NMR spectroscopy. Orthogonal-projection to latent structures discriminant analysis (O-PLS-DA) was applied to model the spectral data and enabled the hepatic, urinary, and serum metabolites that discriminated between control and treated animals to be determined. Histopathological data and clinical chemistry measurements confirmed the protective effect of glycine. The level of N-acetylglucosamine (glcNAc) in the post-dose urine was found to correlate strongly with the degree of galN-induced liver damage, and the urinary level of glcNAc was not significantly elevated in rats treated with both galN and glycine. Treatment with glycine alone was found to significantly increase hepatic levels of uridine, UDP-glucose, and UDP-galactose, and in view of the known effects of galactosamine, this suggests that the protective role of glycine against galN toxicity might be mediated by changes in the uridine nucleotide pool rather than by preventing Kupffer cell activation. Thus, we present a novel hypothesis:  that administration of glycine increases the hepatic uridine nucleotide pool which counteracts the galN-induced depletion of these pools and facilitates complete metabolism of galN. These novel data highlight the applicability of NMR-based metabonomics in elucidating multicompartmental metabolic consequences of toxicity and toxic salvage. Keywords: Metabonomics • Galactosamine Toxicity • Glycine Protection • Mechanism • NMR • O-PLS-DA</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>17580851</pmid><doi>10.1021/pr070164f</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1535-3893
ispartof Journal of proteome research, 2007-07, Vol.6 (7), p.2711-2719
issn 1535-3893
1535-3907
language eng
recordid cdi_crossref_primary_10_1021_pr070164f
source MEDLINE; ACS Publications
subjects Acetylglucosamine - analysis
Animals
Diet
Galactosamine - antagonists & inhibitors
Galactosamine - toxicity
Glycine - administration & dosage
Glycine - blood
Glycine - urine
Kupffer Cells - chemistry
Kupffer Cells - drug effects
Liver - chemistry
Liver - drug effects
Liver - metabolism
Male
Nuclear Magnetic Resonance, Biomolecular - methods
Rats
Rats, Sprague-Dawley
Serum - chemistry
Uridine - analysis
Uridine Diphosphate Galactose - analysis
Uridine Diphosphate Glucose - analysis
Urine - chemistry
title The Mechanism of Galactosamine Toxicity Revisited; A Metabonomic Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T06%3A57%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Mechanism%20of%20Galactosamine%20Toxicity%20Revisited;%20A%20Metabonomic%20Study&rft.jtitle=Journal%20of%20proteome%20research&rft.au=Coen,%20M&rft.date=2007-07&rft.volume=6&rft.issue=7&rft.spage=2711&rft.epage=2719&rft.pages=2711-2719&rft.issn=1535-3893&rft.eissn=1535-3907&rft_id=info:doi/10.1021/pr070164f&rft_dat=%3Cacs_cross%3Ea78346500%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/17580851&rfr_iscdi=true